Page last updated: 2024-08-25
brusatol and Endometrial Hyperplasia
brusatol has been researched along with Endometrial Hyperplasia in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, X; Feng, Y; Fu, Y; Hu, M; Huang, B; Li, J; Liao, H; Qin, Z; Sun, D; Wang, Y; Wei, Y; Wu, S; Yu, J; Zhang, Q; Zhang, Z; Zheng, W; Zhu, H | 1 |
Other Studies
1 other study(ies) available for brusatol and Endometrial Hyperplasia
Article | Year |
---|---|
Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism.
Topics: Animals; DNA-Binding Proteins; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Mice; Mixed Function Oxygenases; NF-E2-Related Factor 2; Progesterone; Progestins; Proto-Oncogene Proteins | 2022 |